Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.
about
Characterization and phylogenetic epitope mapping of CD38 ADPR cyclase in the cynomolgus macaqueFunctional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune SuppressionAlcohol and HIV Effects on the Immune SystemGut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunityA mechanical biomarker of cell state in medicineTranscriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalizationSoluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials studyImmune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infectionEffects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaquesAntibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed MacaquesSystematic identification of synergistic drug pairs targeting HIVClinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hostsHuman immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline.Risk factors associated with low CD4+ lymphocyte count among HIV-positive pregnant women in NigeriaCoexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerA low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.A five-year longitudinal analysis of sooty mangabeys naturally infected with simian immunodeficiency virus reveals a slow but progressive decline in CD4+ T-cell count whose magnitude is not predicted by viral load or immune activationInnate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDSCytomegalovirus-specific responses of CD38⁺ memory T cells are skewed towards IFN-γ and dissociated from CD154 in HIV-1 infectionActivation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.Evolving character of chronic central nervous system HIV infection.Residual immune dysregulation syndrome in treated HIV infection.AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeysGut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?Reduced cellular susceptibility to in vitro HIV infection is associated with CD4+ T cell quiescence.The immune response during acute HIV-1 infection: clues for vaccine development.Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infectionsA novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression.Effect of human immunodeficiency virus infection on plasma bactericidal activity against Salmonella enterica serovar Typhimurium.Characteristics of CD8+ T cell subsets in Chinese patients with chronic HIV infection during initial ART.Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial
P2860
Q24803507-4BE7699C-C7EC-48DF-8E85-52861519B1CBQ26744626-67BC4E5E-A486-404B-B862-15F95AC82B64Q26773216-F7CB2E8C-916E-4CFD-BE7A-A2F7BCD0B694Q26773267-40A03866-C56F-4F91-A87B-262B4F1B460CQ26851354-22D080DC-DB43-4DDD-BC34-AF9A93DFA549Q27318045-E16CD08C-4A70-46E8-8485-2ED73BB1A0B4Q27690715-A31A30B4-84FB-4305-AFBA-77807FAF4F6DQ28475281-5744D669-D3F4-4D97-84DA-6571D04D1ADAQ28478654-7160EDC6-65D7-497C-90E2-97775B8D95A9Q28540858-E1CFF44D-1EFA-41B7-9976-47D044BADD36Q28552448-F315A2E2-DFDA-41CF-AC54-5AEE1786DFFEQ30422333-C09AA0E1-59BA-456C-8A91-780987AF4F3AQ33470290-E3B632FF-7EBD-488E-B9A0-10B2AA8C5779Q33602772-7D108DE2-11AA-40A8-BDE7-05C979EB3235Q33707549-1DB83D6A-3D83-43DF-B221-A814E90CCEDCQ33724256-B4A5C456-35AA-40E8-82B0-DC575A0AB156Q33764938-F7595B3C-FBEB-498E-ACC9-38CDB584AA9FQ33786447-4034AD26-2E90-407F-A764-BBF89D264DB7Q33815728-58E4A782-6961-4292-940D-69D751CA417EQ33856394-CBDE0EA4-D601-410A-B194-F86A4DD96347Q33862741-68C5E601-686C-4903-9215-62E0B7DD15ABQ33877335-FE5450A0-669A-439B-AD41-13D7F1534501Q33883704-CA160222-E2EB-4544-BC78-8321BDF0A1B6Q33916321-ED753DA4-23B1-4CA2-AB30-D83BEBF3E723Q33943390-D0C4298A-3CB6-4764-8A7E-D67F19C9DEDAQ33943429-44AA18B2-F146-43C2-A2B4-43A165EBB701Q33995713-F809B66B-DE2B-447D-BA6E-EFDAA2175185Q34020121-C29BD984-30E1-453E-9FFD-295F7C201DAFQ34047774-C2BCF748-B378-4CF0-B922-101706CCFD6FQ34301788-9C13CBB0-2EA1-4C00-81CE-C24F36C8D6A5Q34315572-1E9D0980-A5FC-4A47-A27F-682493EA4C93Q34373981-A17F2207-D32F-4813-8E59-D80D1081F729Q34412376-505EBCF5-9662-4BF8-9A35-D47C47C1AB5BQ34430345-9E969226-FE28-44DE-927E-8F910187EA78Q34614862-48A23AF7-AB30-4D95-A586-1CE61A5D403EQ34627187-F1541D1F-86F7-43DD-83F1-AF31C743CB93Q34662516-56546878-66C7-409B-BE08-34D0AD05E3AFQ34701418-65A4EC49-143C-44E4-A06E-B82F1C7A75FFQ34778365-69FE10FC-BF1F-45B4-8510-24B1BA1700CFQ35006056-22A46A70-716F-497C-9A42-369FBECA9CD8
P2860
Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Predictive value of immunologi ...... t duration of HIV-1 infection.
@en
Predictive value of immunologi ...... t duration of HIV-1 infection.
@nl
type
label
Predictive value of immunologi ...... t duration of HIV-1 infection.
@en
Predictive value of immunologi ...... t duration of HIV-1 infection.
@nl
prefLabel
Predictive value of immunologi ...... t duration of HIV-1 infection.
@en
Predictive value of immunologi ...... t duration of HIV-1 infection.
@nl
P2093
P1476
Predictive value of immunologi ...... t duration of HIV-1 infection.
@en
P2093
Beth D Jamieson
Charles R Rinaldo
Janis V Giorgi
John P Phair
John W Mellors
Jose L Matud
Lance E Hultin
Robert H Lyles
Roger Detels
Traci E Yamashita
P304
P356
10.1097/00126334-200204010-00004
P407
P577
2002-04-01T00:00:00Z